Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study von Scher, Howard I, Prof, Beer, Tomasz M, MD, Higano, Celestia S, MD, Anand, Aseem, MA, Taplin, Mary-Ellen, MD, Efstathiou, Eleni, MD, Rathkopf, Dana, MD, Shelkey, Julia, BS, Yu, Evan Y, MD, Alumkal, Joshi, MD, Hung, David, MD, Hirmand, Mohammad, MD, Seely, Lynn, MD, Morris, Michael J, MD, Danila, Daniel C, MD, Humm, John, PhD, Larson, Steve, MD, Fleisher, Martin, PhD, Sawyers, Charles L, MD

Volltext

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placeb... von Doody, Rachelle S, Prof, Gavrilova, Svetlana I, Prof, Sano, Mary, Prof, Thomas, Ronald G, Prof, Aisen, Paul S, Prof, Bachurin, Sergey O, Prof, Seely, Lynn, MD, Hung, David, MD

Volltext

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery von Conte, Michael S., Bandyk, Dennis F., Clowes, Alexander W., Moneta, Gregory L., Seely, Lynn, Lorenz, Todd J., Namini, Hamid, Hamdan, Allen D., Roddy, Sean P., Belkin, Michael, Berceli, Scott A., DeMasi, Richard J., Samson, Russell H., Berman, Scott S.

Volltext

Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial von Conte, Michael S., Bandyk, Dennis F., Clowes, Alexander W., Moneta, Gregory L., Namini, Hamid, Seely, Lynn

Volltext

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy von Scher, Howard I, Fizazi, Karim, Saad, Fred, Taplin, Mary-Ellen, Sternberg, Cora N, Miller, Kurt, de Wit, Ronald, Mulders, Peter, Chi, Kim N, Shore, Neal D, Armstrong, Andrew J, Flaig, Thomas W, Fléchon, Aude, Mainwaring, Paul, Fleming, Mark, Hainsworth, John D, Hirmand, Mohammad, Selby, Bryan, Seely, Lynn, de Bono, Johann S

Volltext

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia von Nguyen, Louis L., Moneta, Gregory L., Conte, Michael S., Bandyk, Dennis F., Clowes, Alexander W., Seely, B. Lynn

Volltext

F5‐01‐04: Conducting an Alzheimer's clinical trial in Russia von Seely, Lynn

Volltext

Conducting an Alzheimer's clinical trial in Russia von Seely, Lynn

Volltext

Retroviral expression of a kinase-defective IGF-I receptor suppresses growth and causes apoptosis of CHO and U87 cells in-vivo von Seely, B Lynn, Samimi, Goli, Webster, Nicholas J G

Volltext

Design and Rationale of the PREVENT III Clinical Trial: Edifoligide for the Prevention of Infrainguinal Vein Graft Failure von Conte, Michael S., Lorenz, Todd J., Bandyk, Dennis F., Clowes, Alexander W., Moneta, Gregory L., Seely, B. Lynn

Volltext

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology von Vellas, B, Hampel, H, Rouge-Bugat, M. E, Grundman, M, Andrieu, S, Abu-Shakra, S, Bateman, R, Berman, R, Black, R, Carrillo, M, Donohue, M, Mintun, M, Morris, J, Petersen, R, Thomas, R. G, Suhy, J, Schneider, L, Seely, L, Tariot, P, Touchon, J, Weiner, M, Sampaio, C, Aisen, P

Volltext

Localization of the Insulin-like Growth Factor I Receptor Binding Sites for the SH2 Domain Proteins p85, Syp, and GTPase Activating Protein von Seely, B. Lynn, Reichart, Donna R., Staubs, Patricia A., Jhun, Byung H., Hsu, David, Maegawa, Hiroshi, Milarski, Kim L., Saltiel, Alan R., Olefsky, Jerrold M.

Volltext

O3‐13‐06: Dimebon in Alzheimer's disease: Summary and contrast of three efficacy trials von Doody, Rachelle, Winblad, Bengt, Cummings, Jeffrey, Tariot, Pierre, Sano, Mary, Aisen, Paul, Selby, Bryan, Seely, Lynn

Volltext

Dimebon in Alzheimer's disease: Summary and contrast of three efficacy trials von Doody, Rachelle, Winblad, Bengt, Cummings, Jeffrey, Tariot, Pierre, Sano, Mary, Aisen, Paul, Selby, Bryan, Seely, Lynn

Volltext

Statistical treatment of withdrawal in trials of anti-dementia drugs – Authors' reply von Doody, Rachelle, Seely, Lynn, Thomas, Ronald, Sano, Mary, Aisen, Paul

Volltext

Statistical treatment of withdrawal in trials of anti-dementia drugs/Authors' reply von Mackinnon, Andrew, Doody, Rachelle, Seely, Lynn, Thomas, Ronald, Sano, Mary, Aisen, Paul

Volltext

S4‐01‐02: Results from CONNECTION: A global, Phase 3 double‐blind, placebo‐controlled confirmatory trial of dimebon (latrepirdine) in patients with mild‐to‐moderate Alzheimer's dis... von Doody, Rachelle S., Tariot, Pierre, Cummings, Jeff, Winblad, Bengt, Selby, Bryan, Langenberg, Andria, Seely, Lynn

Volltext

Results from CONNECTION: A global, Phase 3 double-blind, placebo-controlled confirmatory trial of dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease von Doody, Rachelle S, Tariot, Pierre, Cummings, Jeff, Winblad, Bengt, Selby, Bryan, Langenberg, Andria, Seely, Lynn

Volltext

A safety, tolerability and pharmacokinetic study of dimebon in patients with Alzheimer's disease already receiving donepezil von Tariot, Pierre, Sabbagh, Marwan, Flitman, Stephen, Reyes, Patricio, Taber, Louise, Seely, Lynn

Volltext

P1‐254: A safety, tolerability and pharmacokinetic study of dimebon in patients with Alzheimer's disease already receiving donepezil von Tariot, Pierre, Sabbagh, Marwan, Flitman, Stephen, Reyes, Patricio, Taber, Louise, Seely, Lynn

Volltext